SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 208.29-0.3%Nov 11 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kha vu who wrote (21084)5/19/1998 10:02:00 AM
From: bob smith  Read Replies (1) of 32384
 
Here is Juback's update on Ligand (5/19/98):

Updates
New Developments on Past Columns

Stocking up on Biotech
Michael Murphy, editor of the California Technology Stock Letter, picked Ligand Pharmaceuticals
(LGND) as one of his favorite biotech stocks at the lunchtime technology investing panel at the recent
Money Show in Las Vegas. By Murphy's count, the company has 39 drugs in the pipeline that should
be ready for Food & Drug Administration approval sometime in the next three years.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext